HK1084102A1 - Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cellsand pharmaceutical compositions comprising the sa me - Google Patents

Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cellsand pharmaceutical compositions comprising the sa me

Info

Publication number
HK1084102A1
HK1084102A1 HK06104137A HK06104137A HK1084102A1 HK 1084102 A1 HK1084102 A1 HK 1084102A1 HK 06104137 A HK06104137 A HK 06104137A HK 06104137 A HK06104137 A HK 06104137A HK 1084102 A1 HK1084102 A1 HK 1084102A1
Authority
HK
Hong Kong
Prior art keywords
cellsand
tumor
inhibiting
cancer
growth
Prior art date
Application number
HK06104137A
Other languages
English (en)
Inventor
Lee Sen-Bin
Chiu-Ming Chen
Original Assignee
Taiwan Sunpan Biotechnology De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiwan Sunpan Biotechnology De filed Critical Taiwan Sunpan Biotechnology De
Publication of HK1084102A1 publication Critical patent/HK1084102A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
HK06104137A 2004-05-21 2006-04-04 Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cellsand pharmaceutical compositions comprising the sa me HK1084102A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100475473A CN100413868C (zh) 2004-05-21 2004-05-21 分离自藤黄树脂并具有抑制肿瘤/癌细胞生长活性的化合物以及包含其的药物组合物

Publications (1)

Publication Number Publication Date
HK1084102A1 true HK1084102A1 (en) 2006-07-21

Family

ID=35170010

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06104137A HK1084102A1 (en) 2004-05-21 2006-04-04 Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cellsand pharmaceutical compositions comprising the sa me

Country Status (3)

Country Link
EP (1) EP1619195A3 (zh)
CN (1) CN100413868C (zh)
HK (1) HK1084102A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007121352A2 (en) * 2006-04-13 2007-10-25 Regents Of The University Of Minnesota Therapeutic triterpenoids
TWI432191B (zh) 2010-06-11 2014-04-01 Taiwan Sunpan Biotechnology Dev Co Ltd 分離自藤黃樹脂的化合物以及包含有此等化合物的藥學組成物
CN102276621B (zh) * 2010-06-11 2015-01-07 台湾森本生物科技开发股份有限公司 分离自藤黄树脂的化合物暨其衍生物,以及包含有此等化合物与衍生物的药学组成物
CN103421021B (zh) * 2010-06-11 2016-08-10 台湾森本生物科技开发股份有限公司 分离自藤黄树脂的化合物暨其衍生物，以及包含有此等化合物与衍生物的药学组成物
CN103664997A (zh) * 2013-11-28 2014-03-26 江苏康缘药业股份有限公司 从藤黄中提取的抗肿瘤化合物及其制备方法与用途
CN103694248B (zh) * 2013-11-28 2017-01-25 江苏康缘药业股份有限公司 从藤黄中提取的抗肿瘤化合物及其制备方法与用途
WO2015153933A1 (en) * 2014-04-03 2015-10-08 The Children's Medical Center Corporation Hsp90 inhibitors for the treatment of obesity and methods of use thereof
CN107056743B (zh) * 2016-11-21 2019-09-13 云南民族大学 一种缩酚酸环醚化合物及其制备方法和应用
TWI728709B (zh) * 2020-02-19 2021-05-21 台灣森本生物科技開發股份有限公司 含有得自於藤黃樹脂的丙酮萃取產物的藥學組成物以及由該組成物所製得的配方
CN114324725B (zh) * 2021-12-24 2023-12-22 承德燕峰药业有限责任公司 一种照山白浸膏片的梯度全信息薄层鉴别方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08231396A (ja) * 1995-02-28 1996-09-10 Terumo Corp 抗ヘリコバクター・ピロリ薬
JPH09227545A (ja) * 1996-02-26 1997-09-02 Mitsubishi Chem Corp フロログルシン誘導体
JP3968405B2 (ja) * 1996-08-30 2007-08-29 株式会社ロッテホールディングス 抗アレルギー剤
JP2000072665A (ja) * 1998-08-31 2000-03-07 Kikkoman Corp ヒアルロニダーゼ阻害剤
JP4630416B2 (ja) * 2000-03-02 2011-02-09 株式会社ロッテ 坑う蝕、歯周病剤
CN1109034C (zh) * 2001-01-17 2003-05-21 中国药科大学 具抗癌活性的藤黄酸类化合物的复合物及其制备方法
CN1245407C (zh) * 2002-06-17 2006-03-15 杭州博大药物研究所 藤黄酸类化合物的复合物,其制备方法和以该复合物为活性成份的药物组合物
CN1289506C (zh) * 2002-07-23 2006-12-13 杭州博大药物研究所 藤黄酸类化合物的复合物,其制备方法及以该复合物为活性成份的药物组合物
JP2004137210A (ja) * 2002-10-18 2004-05-13 Eag Kk 血小板活性化因子抑制剤、化粧品、および医薬品
TWI282280B (en) * 2004-05-21 2007-06-11 Taiwan Sunpan Biotechnology De Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cells and pharmaceutical compositions comprising the same

Also Published As

Publication number Publication date
EP1619195A2 (en) 2006-01-25
EP1619195A3 (en) 2007-03-28
CN1699368A (zh) 2005-11-23
CN100413868C (zh) 2008-08-27

Similar Documents

Publication Publication Date Title
HK1084102A1 (en) Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cellsand pharmaceutical compositions comprising the sa me
EP1765391A4 (en) BACTERIAL COMPOSITIONS FOR THE TREATMENT OF CANCER
ZA200707638B (en) Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
EP1819341A4 (en) IL-12 MODULATORY CONNECTIONS
IL190882A0 (en) Compositions for cancer therapy
EP1906948A4 (en) TREATMENT OF CANCER
HK1105886A1 (zh) 含有 的治療癌腫瘤的藥物組合物
HK1164767A1 (zh) 治療癌症的化合物及方法
ZA200710206B (en) Compositions and methods for inhibition of the JAK path-way
IL189377A0 (en) Combinations comprising dmxaa for the treatment of cancer
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
IL189376A0 (en) Combinations comprising dmxaa for the treatment of cancer
GB2443588B (en) A pharmaceutical composition useful for the treatment of prostate cancer
EP1904088A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
EP1693069A4 (en) MEANS FOR THE TREATMENT OF SOLID TUMORS
ZA200706871B (en) Treatment of metastasized tumors
GB0410379D0 (en) Treatment of cancer
GB0517386D0 (en) Combinations for the treatment of cancer
GB0423273D0 (en) Treatment of cancer
EP1905445A4 (en) HUMBLER OF TUMOR GROWTH
GB0409794D0 (en) Preservation of feed
GB0420845D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220521